| PERIOD ENDING | 10-Oct-09 | 18-Jul-09 | 25-Apr-09 | 3-Jan-09 | | Total Revenue | 602,570 | 614,448 | 807,007 | 621,592 | | Cost of Revenue | 322,245 | 333,339 | 429,462 | 321,606 | | | Gross Profit | 280,325 | 281,109 | 377,545 | 299,986 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 207,172 | 216,602 | 294,022 | 228,081 | | Non Recurring | 3,013 | (3,013) |
-
| 3,108 | | Others | 19,064 | 18,656 | 24,277 | 18,994 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 51,076 | 48,864 | 59,246 | 49,803 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,955 | 2,986 | 4,054 | 3,244 | | Earnings Before Interest And Taxes | 54,031 | 51,850 | 63,300 | 53,047 | | Interest Expense | 2,857 | 2,806 | 3,595 | 3,060 | | Income Before Tax | 51,174 | 49,044 | 59,705 | 49,987 | | Income Tax Expense | 18,150 | 17,947 | 21,872 | 17,732 | | Minority Interest | (2,306) |
-
|
-
| (169) | | | | Net Income From Continuing Ops | 30,718 | 31,097 | 37,833 | 32,086 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,718 | 31,097 | 37,833 | 32,086 | | Preferred Stock And Other Adjustments | 1,208 | (756) | (452) |
-
| | | Net Income Applicable To Common Shares | $31,926 | $30,341 | $37,381 | $32,086 |
|
1.52% Nasdaq 0.00%
Income Statement
